Journal Article
Estimated Annual Spending on Lecanemab and Its Ancillary Costs in the US Medicare Program
To estimate annual Medicare spending on lecanemab, we performed a cost analysis using nationally representative survey data from the 2018 Health and Retirement Study (HRS).
May 17, 2023